Metabolic Syndrome
- PMID: 29083742
- Bookshelf ID: NBK459248
Metabolic Syndrome
Excerpt
Metabolic syndrome is an accumulation of several disorders that raise the risk of atherosclerotic cardiovascular disease, including myocardial infarction, cerebrovascular accidents, peripheral vascular diseases, insulin resistance, and type II diabetes mellitus. The cluster of metabolic disorders that define metabolic syndrome includes central obesity, insulin resistance, hypertension, and atherogenic dyslipidemia.
The diagnosis of metabolic syndrome requires the presence of 3 or more metabolic abnormalities:
A waist circumference of more than 40 inches in men and 35 inches in women
Serum triglycerides level of 150 mg/dL or greater
Reduced high-density lipoprotein cholesterol, less than 40 mg/dL in men or less than 50 mg/dL in women
Elevated fasting glucose of l00 mg/dL or greater
Blood pressure values of systolic 130 mm Hg or higher or diastolic 85 mm Hg or higher
Patients with metabolic syndrome are estimated to have a 2-fold increased risk of atherosclerotic cardiovascular diseases and a 5-fold increased risk of diabetes mellitus, as compared to the general population. Metabolic syndrome is also associated with accelerated atherosclerosis, premature atherosclerotic cardiovascular diseases, and early onset type II diabetes mellitus. The sedentary lifestyle and excess consumption of calories have significantly increased the proportion of the population with obesity in the last few decades. Due to this exponential growth in population obesity, the incidence of metabolic syndrome has increased significantly over the last 2 decades. Currently, more than one-fifth of Americans, as well as the European population, are suffering from metabolic syndrome.
Central obesity is the primary component of metabolic syndrome, leading to insulin resistance, hypertension, and dyslipidemia. The clinical presentation of metabolic syndrome is variable and depends on the underlying atherosclerotic cardiovascular disease. The common signs of metabolic syndrome include abdominal obesity with high body mass index and increased waist circumference, elevated blood pressure, and signs of insulin resistance. Metabolic syndrome has serious implications for an individual’s health. The prevalence of metabolic syndrome is rising, and through intervention, the progression can be halted and potentially reversed.
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Sections
- Continuing Education Activity
- Introduction
- Etiology
- Epidemiology
- Pathophysiology
- History and Physical
- Evaluation
- Treatment / Management
- Differential Diagnosis
- Prognosis
- Complications
- Consultations
- Deterrence and Patient Education
- Pearls and Other Issues
- Enhancing Healthcare Team Outcomes
- Review Questions
- References
References
-
- Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC, International Diabetes Federation Task Force on Epidemiology and Prevention. Hational Heart, Lung, and Blood Institute. American Heart Association. World Heart Federation. International Atherosclerosis Society. International Association for the Study of Obesity Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009 Oct 20;120(16):1640-5. - PubMed
-
- Samson SL, Garber AJ. Metabolic syndrome. Endocrinol Metab Clin North Am. 2014 Mar;43(1):1-23. - PubMed
-
- Pucci G, Alcidi R, Tap L, Battista F, Mattace-Raso F, Schillaci G. Sex- and gender-related prevalence, cardiovascular risk and therapeutic approach in metabolic syndrome: A review of the literature. Pharmacol Res. 2017 Jun;120:34-42. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Medical